| Financial Year |
March 31 2023 |
| Monetary Funds |
317,438,370.63 |
| Held-for-trading Financial Assets |
98,079,371.07 |
| Notes Receivable |
5,926,648.77 |
| Accounts Receivable |
71,572,333.47 |
| Advances to Suppliers |
48,153,827.18 |
| Other Receivables |
4,830,951.42 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
208,450.89 |
| Inventories |
42,769,676.50 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
1,503,347.15 |
| Other Current Assets |
1,372,847.09 |
| Total Current Assets |
593,478,766.40 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,216,159.46 |
| Long-term Equity Investment |
478,258,235.98 |
| Investment Properties |
6,019,888.93 |
| Fixed Assetes |
85,930,722.17 |
| Under-construction Projects |
1,032,397.73 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
253,203,215.36 |
| R&D expenses |
-- |
| Goodwill |
63,701,068.65 |
| Long-Term Deferred and Prepaid Expenses |
34,275,985.23 |
| Deferred Income Tax Assets |
35,919,853.09 |
| Other Non-Current Assets |
7,764,000.00 |
| Sub-Total of Non-Current Assets |
1,116,067,090.15 |
| Total Assets |
1,709,545,856.55 |
| Short-Term Loans |
285,292,916.69 |
| Trading Financial liabilities |
-- |
| Notes Payable |
110,000,000.00 |
| Accounts Payable |
140,480,877.86 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
7,468,470.67 |
| Taxes Payable |
6,712,483.38 |
| Interest Payable |
-- |
| Dividend Payable |
53,514.51 |
| Other payables |
78,476,964.72 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
18,667,917.88 |
| Other Current Liabilities |
2,975,720.47 |
| Sub-Total of Current Liabilities |
672,525,200.50 |
| Long-term Loans |
73,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
3,689,500.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
94,449,347.37 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
290,149,227.94 |
| Total Liabilities |
962,674,428.44 |
| Paid-In Capital(Or Share Stock) |
310,593,879.00 |
| Capital Surplus |
261,731,708.54 |
| Surplus Reserve |
105,696,777.80 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
102,731,513.64 |
| Minority Stockholder's Interest |
190,738,986.83 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
556,132,441.28 |
| Owner's Equity（Stockholder's Equity） |
746,871,428.11 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,709,545,856.55 |
